Search results for "double-blind method"

showing 10 items of 631 documents

Non-celiac wheat sensitivity as an allergic condition: personal experience and narrative review.

2013

Non-celiac wheat sensitivity (NCWS) is a newly described clinical entity characterized by symptoms, which can involve the gastrointestinal tract, the nervous system, the skin, and other organs. There is little data on the pathogenesis of NCWS and it is probable that different pathogenic mechanisms are involved in the different clinical manifestations of the disease. The only common denominator of NCWS "syndrome" is wheat consumption: the symptoms disappear on exclusion of wheat from the diet, and reappear on wheat consumption. The objective of this study was to review our prior data regarding NCWS and to review relevant medical literature regarding NCWS, with particular attention to the hyp…

MalePathologymedicine.medical_specialtySettore MED/09 - Medicina InternaNon-celiac wheat sensitivityGastrointestinal DiseasesMEDLINEAllergic conditionIrritable Bowel SyndromeDouble-Blind MethodMedicineHumansSensitivity (control systems)Triticumfood allergyHepatologybusiness.industryGastroenterologynutritional and metabolic diseasesfood and beveragesdigestive system diseasesCeliac DiseaseImmunoglobulin GNarrative reviewFemalebusinessFood HypersensitivityClinical psychologyThe American journal of gastroenterology
researchProduct

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-co…

2005

Objective The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with five doses of acellular pertussis–containing vaccine. Study design Adolescents (n = 319) previously vaccinated with either 5 doses of diphtheria–tetanus–acellular pertussis (DTaP) (n = 193) or 4 doses of DTaP plus another acellular pertussis–containing vaccine received one dose each of Tdap and hepatitis A vaccine in a double-blinded, randomized, crossover trial. Rates of adverse events (AEs) after vaccination with Tdap versus hepatitis A and rates of local AEs among adolescents vaccinated with Tdap (sixth acellular…

MalePediatricsmedicine.medical_specialtyAdolescentWhooping CoughHepatitis A vaccineBooster doseDiphtheria-Tetanus-acellular Pertussis Vaccinescomplex mixturesSeverity of Illness IndexDouble-Blind MethodGermanymedicineHumansProspective StudiesAdverse effectChildWhooping coughImmunization ScheduleAntigens BacterialCross-Over StudiesTetanusDose-Response Relationship Drugbusiness.industryTetanusDiphtheriaIncidenceVaccinationHepatitis ADiphtheriamedicine.diseaseSurgeryVaccinationTreatment OutcomePediatrics Perinatology and Child HealthFemalebusinessFollow-Up StudiesThe Journal of pediatrics
researchProduct

Persistent cow's milk protein intolerance in infants: the changing faces of the same disease

1998

Background Recent research has shown that cow's milk protein intolerance (CMPI) often persists beyond 4 years of age. Aims To evaluate the clinical and immunological characteristics of a group of infants with persistent CMPI. Patients and methods Twelve infants (6 m, 6f) with persistent CMPI were followed up from birth until a median age of 5 years. The patients underwent CMP challenge each year to evaluate CMP-tolerance. As controls we followed 26 infants (12 m, 14 f) with CMPI that resolved within 1–2 years. Results A family history of atopic disease was found in 10/12 patients with persistent CMPI and in 10/26 controls (P < 0.01). Clinical presentation changed over time: at onset symptom…

MalePediatricsmedicine.medical_specialtyConstipationImmunologyDiseaseRadioallergosorbent TestDouble-Blind MethodmedicineAnimalsHumansImmunology and AllergyFamily historyChildAsthmaMilk proteinbusiness.industryInfant NewbornInfantVery high frequencyImmunoglobulin EMilk Proteinsmedicine.diseaseFood intoleranceCow's milk proteinChild PreschoolImmunoglobulin GImmunologyCattleFemaleMilk Hypersensitivitymedicine.symptombusinessClinical &amp; Experimental Allergy
researchProduct

Fermented Milk Consumption and Common Infections in Children Attending Day-Care Centers: A Randomized Trial

2016

Supplemental Digital Content is available in the text

MalePediatricsmedicine.medical_specialtyLactobacillus caseiCultured Milk ProductsDay careCommunicable Diseaseslaw.invention03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled trialrespiratory infectionlaw030225 pediatricsLactobacillus casei CNCM I-1518Cultured Milk ProductsmedicineAnimalsHumans030212 general & internal medicineChildbiologybusiness.industryIncidenceProbioticsIncidence (epidemiology)rhinopharyngitisOriginal Articles: NutritionGastroenterologyfood and beveragesChild Day Care Centersbiology.organism_classificationClinical trialLacticaseibacillus caseiMilkMulticenter studyCommon infectious diseasesChild PreschoolFermentationPediatrics Perinatology and Child HealthComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFemalebusinessLactobacillus caseigastrointestinal infectionJournal of Pediatric Gastroenterology &amp; Nutrition
researchProduct

Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity diso…

2019

The present study investigated whether symptom reduction in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) treated with guanfacine extended release (GXR) can be explained by sedative effects of the medication. Data from four double-blind, randomized, placebo-controlled, phase 3 trials of GXR monotherapy (1-7 mg/day; morning administration) in children (aged 6-12 years) and adolescents (aged 13-17 years) with ADHD were analyzed post hoc. Two studies used forced-dose titration and two used flexible-dose titration. Efficacy was determined using ADHD Rating Scale IV (ADHD-RS-IV) scores. Sedative treatment-emergent adverse events (TEAEs) included somnolence, sedati…

MalePediatricsmedicine.medical_specialtyTime FactorsAdolescentmedicine.drug_classSedationDrug Administration Schedule03 medical and health sciences0302 clinical medicineDouble-Blind MethodRating scalemedicineHumansHypnotics and SedativesAttention deficit hyperactivity disorderPharmacology (medical)ChildAdverse effectBiological PsychiatryMorningPsychiatric Status Rating ScalesPharmacologyDose-Response Relationship Drugbusiness.industrymedicine.diseaseGuanfacine030227 psychiatryGuanfacinePsychiatry and Mental healthTreatment OutcomeNeurologyAttention Deficit Disorder with HyperactivityDelayed-Action PreparationsSedativeFemaleNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgerySomnolenceFollow-Up Studiesmedicine.drugEuropean Neuropsychopharmacology
researchProduct

Cognitive-behavioral screening in elderly patients with new-onset epilepsy before treatment

2014

Objectives Cognitive comorbidity at epilepsy onset reflects disease severity and provides a baseline estimate of reserve capacities with regard to the effects of epilepsy and its treatment. Given the high incidence of epilepsy at an older age, this study analyzed objective and subjective cognition as well as quality of life in elderly patients with new-onset focal epilepsy before initiation of anti-epileptic treatment. Materials and methods A total of 257 untreated patients (60–95 years of age) with new-onset epilepsy underwent objective assessment of executive function (EpiTrack) and performed subjective ratings of cognition (Portland Neurotoxicity Scale) and quality of life (QoL; QOLIE-31…

MalePediatricsmedicine.medical_specialtymedia_common.quotation_subjectComorbidityExecutive FunctionEpilepsyDouble-Blind MethodmedicineHumansAgedmedia_commonAged 80 and overEpilepsyIncidenceNeuropsychologyCognitionGeneral MedicineMiddle AgedExecutive functionsmedicine.diseaseComorbidityNeurologyQuality of LifeEtiologyPhysical therapyAnticonvulsantsFemaleNeurology (clinical)Cognition DisordersPsychologyBody mass indexVigilance (psychology)Acta Neurologica Scandinavica
researchProduct

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (E…

2015

Summary Background Alisporivir (ALV) is an oral, host-targeting agent with pangenotypic anti-hepatitis C virus (HCV) activity and a high barrier to resistance. Aim To evaluate efficacy and safety of ALV plus peginterferon-α2a and ribavirin (PR) in treatment-naive patients with chronic HCV genotype 1 infection. Methods Double-blind, randomised, placebo-controlled, Phase 3 study evaluating ALV 600 mg once daily [response-guided therapy (RGT) for 24 or 48 weeks or 48 weeks fixed duration] or ALV 400 mg twice daily RGT with PR, compared to PR alone. Following a Food and Drug Administration partial clinical hold, ALV/placebo was discontinued and patients completed treatment with PR only. At that…

MalePhases of clinical researchHepacivirusGastroenterologyPolyethylene GlycolPolyethylene Glycolschemistry.chemical_compoundMedicinePharmacology (medical)ChronicAlisporivirAdolescent; Adult; Aged; Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy Combination; Female; Genotype; Hepacivirus; Hepatitis C Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; United States; Young AdultGastroenterologyHepatitis CRecombinant ProteinMiddle AgedHepatitis CRecombinant ProteinsTreatment OutcomeCombinationCyclosporineDrug Therapy CombinationFemaleHumanUnited StateAdultmedicine.medical_specialtyAdolescentGenotypeAlpha interferonPlaceboAntiviral AgentsYoung AdultDrug TherapyDouble-Blind MethodInternal medicineRibavirinHumansAdverse effectAgedAntiviral AgentHepaciviruHepatologybusiness.industryRibavirinInterferon-alphaHepatitis C Chronicmedicine.diseaseUnited StatesRegimenchemistryImmunologybusinessAlimentary pharmacologytherapeutics
researchProduct

Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task.

2011

Treatment of Alzheimer's disease (AD) with acetylcholinesterase inhibitors (AChEI) enhances cholinergic activity and alleviates clinical symptoms. In the present functional magnetic resonance imaging (fMRI) study, we investigated the effect of the AChEI rivastigmine on cognitive function and brain activation patterns during a face recognition memory task. Twenty patients with newly-diagnosed mild AD were administered a single oral dose of placebo, a single dose of rivastigmine (acute), and twice-daily treatment with rivastigmine for 4 weeks (chronic). After each treatment, the patients underwent a facial recognition task during fMRI. The prefrontal areas known to be involved in face recogni…

MalePhenylcarbamatesRivastigmineBrain mappingDouble-Blind MethodAlzheimer DiseaseMemorymedicineImage Processing Computer-AssistedHumansPrefrontal cortexCognitive reserveRecognition memoryAgedRivastigmineBrain Mappingmedicine.diagnostic_testWorking memoryCognitionMagnetic Resonance ImagingNeurologyPattern Recognition VisualFemaleNeurology (clinical)Cholinesterase InhibitorsFunctional magnetic resonance imagingPsychologyNeurosciencemedicine.drugCurrent Alzheimer research
researchProduct

Anodal transcranial direct current stimulation and intermittent theta-burst stimulation improve deglutition and swallowing reproducibility in elderly…

2019

Background: Dysphagia in the elderly, known as presbydysphagia, has become a relevant public health problem in several countries. Swallowing disorders may be a consequence of different neurological disorders (secondary presbydysphagia) or the expression of the aging process itself (primary presbydysphagia). We aimed to test the therapeutic potential of two different non-invasive brain stimulation (NIBS) techniques in subjects with primary or secondary presbydysphagia. Methods: A blinded randomized controlled trial with crossover design was carried out in 42 patients, randomly assigned to anodal transcranial direct current stimulation (tDCS) or intermittent theta-burst stimulation (TBS) grou…

MalePhysiologymedicine.medical_treatmentbrain stimulationStimulationTranscranial Direct Current StimulationtDCSlaw.invention030507 speech-language pathology & audiology03 medical and health sciences0302 clinical medicineSwallowingRandomized controlled trialDouble-Blind MethodlawmedicineHumansTBSProspective StudiesAgedCross-Over StudiesTranscranial direct-current stimulationEndocrine and Autonomic Systemsbusiness.industrySwallowing DisordersGastroenterologyMotor CortexCrossover studyDysphagiaDeglutitionTreatment OutcomepresbydysphagiaBrain stimulationAnesthesiaTMSFemalemedicine.symptom0305 other medical sciencebusinessDeglutition Disorders030217 neurology & neurosurgery
researchProduct

Effects of caffeine on neuromuscular function in a non‐fatigued state and during fatiguing exercise

2020

New findings What is the central question of the study? What are the effects of caffeine on neuromuscular function in a non-fatigued state and during fatiguing exercise? What is the main finding and its importance? In a non-fatigued state, caffeine decreased the duration of the silent period evoked by transcranial magnetic stimulation. Caffeine-induced reduction of inhibitory mechanisms in the central nervous system before exercise was associated with an increased performance. Individuals who benefit from caffeine ingestion may experience lower perception of effort during exercise and an accelerated recovery of M-wave amplitude postfatigue. This study elucidates the mechanisms of action of …

MalePhysiologyväsymysmedicine.medical_treatmentliikunta030204 cardiovascular system & hematologyRC1200H-Reflexchemistry.chemical_compound0302 clinical medicineTriceps surae muscletranscranial magnetic stimulationMedicinerasitusMotor NeuronsNutrition and DieteticsMotor CortexGeneral MedicineTranscranial Magnetic Stimulationhermo-lihastoimintamedicine.anatomical_structureNeuromuscular AgentsMuscle FatigueCaffeineMuscle ContractionAdultmedicine.medical_specialtyQP301.H75_Physiology._Sport.Postureperipheral fatiguePlacebo03 medical and health sciencesPhysical medicine and rehabilitationDouble-Blind MethodCaffeinePhysiology (medical)Humansrate of perceived exertionExercisesoleussuorituskykySoleus musclePyramidal tractsbusiness.industryEvoked Potentials MotorQPCrossover studycentral fatigueTranscranial magnetic stimulationchemistrykofeiiniSilent periodbusiness030217 neurology & neurosurgeryExperimental Physiology
researchProduct